The Laerdal Million Lives Fund is committed to investing in, partnering with and supporting entrepreneurs who are developing and deploying new emerging technologies capable of saving lives across the globe. We target investments in commercial stage technologies that (i) address mortality rates across clinical areas, such as maternal, neonatal, emergency medicine, critical care, surgery and others, and (ii) provide better medical education and training to providers and patients. We prioritize investments that can meaningful impact mortality rates at a global scale by improving healthcare quality and outcomes regardless of demographic or geography, thus contributing directly to our global goal of saving 1 million lives annually by 2030.